433 related articles for article (PubMed ID: 31328369)
1. National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017.
Su ZT; Segal JB; Lanzkron S; Ogunsile FJ
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1246-1250. PubMed ID: 31328369
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children.
Brousseau DC; Richardson T; Hall M; Ellison AM; Shah SS; Raphael JL; Bundy DG; Arnold S
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31227564
[TBL] [Abstract][Full Text] [Related]
3. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
Kang HA; Barner JC
J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
[No Abstract] [Full Text] [Related]
4. National opioid prescribing trends in emergency departments by provider type: 2005-2015.
Yang BK; Storr CL; Trinkoff AM; Sohn M; Idzik SK; McKinnon M
Am J Emerg Med; 2019 Aug; 37(8):1439-1445. PubMed ID: 30377010
[TBL] [Abstract][Full Text] [Related]
5. Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline.
Kang HA; Wang B; Barner JC; Ataga KI; Mignacca RC; Chang A; Zhang Y
JAMA Intern Med; 2024 May; 184(5):510-518. PubMed ID: 38466269
[TBL] [Abstract][Full Text] [Related]
6. Trends in Office Visits During Which Opioids Were Prescribed for Adults With Arthritis in the US, 2006-2015.
Santo L; Schappert SM; Hootman JM; Helmick CG
Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1430-1435. PubMed ID: 32937030
[TBL] [Abstract][Full Text] [Related]
7. Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.
Rhee TG
J Gerontol A Biol Sci Med Sci; 2019 Nov; 74(12):1910-1915. PubMed ID: 30561526
[TBL] [Abstract][Full Text] [Related]
8. U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency department visits from 2006 to 2015.
Vijay A; Rhee TG; Ross JS
Prev Med; 2019 Jun; 123():123-129. PubMed ID: 30894321
[TBL] [Abstract][Full Text] [Related]
9. Opioid prescribing rates from the emergency department: Down but not out.
Ali MM; Cutler E; Mutter R; Henke RM; Mazer-Amirshahi M; Pines JM; Cummings N
Drug Alcohol Depend; 2019 Dec; 205():107636. PubMed ID: 31704377
[TBL] [Abstract][Full Text] [Related]
10. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
Lanzkron S; Haywood C; Hassell KL; Rand C
J Natl Med Assoc; 2008 Aug; 100(8):968-73. PubMed ID: 18717150
[TBL] [Abstract][Full Text] [Related]
11. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.
Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):885-92. PubMed ID: 25906971
[TBL] [Abstract][Full Text] [Related]
12. Changes in opioid prescriptions for Medicaid-enrolled children and young adults, 2012-2016.
Masonbrink A; Richardson T; Delzeit J; Miller MK; Hall M; Catley D
J Opioid Manag; 2020; 16(6):451-460. PubMed ID: 33428192
[TBL] [Abstract][Full Text] [Related]
13. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments.
Pletcher MJ; Kertesz SG; Kohn MA; Gonzales R
JAMA; 2008 Jan; 299(1):70-8. PubMed ID: 18167408
[TBL] [Abstract][Full Text] [Related]
14. Opioid Prescribing Patterns Following Pediatric Tonsillectomy in the United States, 2009-2017.
Qian ZJ; Alyono JC; Jin MC; Cooperman SP; Cheng AG; Balakrishnan K
Laryngoscope; 2021 May; 131(5):E1722-E1729. PubMed ID: 33026683
[TBL] [Abstract][Full Text] [Related]
15. Trends in Opioids Prescribed at Discharge From Emergency Departments Among Adults: United States, 2006-2017.
Rui P; Santo L; Ashman JJ
Natl Health Stat Report; 2020 Jan; (135):1-12. PubMed ID: 32510308
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016.
Soprano SE; Hennessy S; Bilker WB; Leonard CE
JAMA Netw Open; 2020 Jun; 3(6):e207664. PubMed ID: 32579193
[TBL] [Abstract][Full Text] [Related]
17. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
Shukla N; Barner JC; Lawson KA; Rascati KL
J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
[TBL] [Abstract][Full Text] [Related]
18. Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014-2016 National Ambulatory Medical Care Survey.
Santo L; Rui P; Ashman JJ
Natl Health Stat Report; 2020 Jan; (137):1-16. PubMed ID: 32510318
[TBL] [Abstract][Full Text] [Related]
19. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.
Pincus HA; Tanielian TL; Marcus SC; Olfson M; Zarin DA; Thompson J; Magno Zito J
JAMA; 1998 Feb; 279(7):526-31. PubMed ID: 9480363
[TBL] [Abstract][Full Text] [Related]
20. Opioid Prescription Filling Trends Among Children with Sickle Cell Disease After the Release of State-Issued Guidelines on Pain Management.
Creary SE; Chisolm DJ; Wrona SK; Cooper JN
Pain Med; 2020 Oct; 21(10):2583-2592. PubMed ID: 32142138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
